相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer
Erina Takai et al.
ANNALS OF SURGERY (2022)
Characterizing allele- and haplotype-specific copy numbers in single cells with CHISEL
Simone Zaccaria et al.
NATURE BIOTECHNOLOGY (2021)
Copy neutral loss of heterozygosity (cnLOH) patterns in synchronous colorectal cancer
Sandra Tapial et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2021)
HLA loss of heterozygosity-mediated discordant responses to immune checkpoint blockade in squamous cell lung cancer with renal metastasis
Sheng Yu et al.
IMMUNOTHERAPY (2021)
Overcoming resistance to endocrine therapy in hormone receptor-positive human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a meta-analysis and systemic review of randomized clinical trials
Wenjie Zhu et al.
FRONTIERS OF MEDICINE (2021)
PTEN in Chromatin Remodeling
Jingyi Yang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
Saioa Lopez et al.
NATURE GENETICS (2020)
Overcoming Endocrine Resistance in Breast Cancer
Ariella B. Hanker et al.
CANCER CELL (2020)
Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
Veronica Rendo et al.
NATURE COMMUNICATIONS (2020)
Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities
Caitlin A. Nichols et al.
NATURE COMMUNICATIONS (2020)
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome
Evan Rosenbaum et al.
CLINICAL CANCER RESEARCH (2020)
Pervasive chromosomal instability and karyotype order in tumour evolution
Thomas B. K. Watkins et al.
NATURE (2020)
Nuclear Heparanase Regulates Chromatin Remodeling, Gene Expression and PTEN Tumor Suppressor Function
Rada Amin et al.
CELLS (2020)
Common germline-somatic variant interactions in advanced urothelial cancer
Aram Vosoughi et al.
NATURE COMMUNICATIONS (2020)
Immune Escape Mechanisms in Non Small Cell Lung Cancer
Andrea Anichini et al.
CANCERS (2020)
Pan-cancer landscape of homologous recombination deficiency
Luan Nguyen et al.
NATURE COMMUNICATIONS (2020)
Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods
Maria de Lourdes L. F. Chauffaille et al.
HEMATOLOGY TRANSFUSION AND CELL THERAPY (2020)
Role of a novel race-related tumor suppressor microRNA located in frequently deleted chromosomal locus 8p21 in prostate cancer progression
Divya Bhagirath et al.
CARCINOGENESIS (2019)
The influence of BRCA2 mutation on localized prostate cancer
Renea A. Taylor et al.
NATURE REVIEWS UROLOGY (2019)
Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene
Mark J. Demma et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
The RB1 Story: Characterization and Cloning of the First Tumor Suppressor Gene
Jesse L. Berry et al.
GENES (2019)
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
Alice Newey et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer
Yufeng Ding et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
SMAD4 Somatic Mutations in Head and Neck Carcinoma Are Associated With Tumor Progression
Li-Han Lin et al.
FRONTIERS IN ONCOLOGY (2019)
The global challenge of colorectal cancer
Marianne Gronlie Guren
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors
Annelies Verbiest et al.
CLINICAL GENITOURINARY CANCER (2018)
TRACERx: Tracking tumor evolution to impact the course of lung cancer
Marcelo Vailati Negrao et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)
Genome doubling shapes the evolution and prognosis of advanced cancers
Craig M. Bielski et al.
NATURE GENETICS (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy
William C. Stafford et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The Expanding World of N-MYC-Driven Tumors
David S. Rickman et al.
CANCER DISCOVERY (2018)
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
Ben Lawrence et al.
NPJ GENOMIC MEDICINE (2018)
Role of p53 Gene in Breast Cancer: Focus on Mutation Spectrum and Therapeutic Strategies
Raman Preet Kaur et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
Elena J. Orlando et al.
NATURE MEDICINE (2018)
Contribution of allelic imbalance to colorectal cancer
Kimmo Palin et al.
NATURE COMMUNICATIONS (2018)
Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours
Aurelie Durgeau et al.
NATURE COMMUNICATIONS (2018)
Cancer Navigation Strategy for Endocrine Therapy-Resistant Breast Tumors
Mitsuyoshi Nakao et al.
TRENDS IN CANCER (2018)
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Zbyslaw Sondka et al.
NATURE REVIEWS CANCER (2018)
Why are there hotspot mutations in the TP53 gene in human cancers?
Evan H. Baugh et al.
CELL DEATH AND DIFFERENTIATION (2018)
Negative selection in tumor genome evolution acts on essential cellular functions and the immunopeptidome
Luis Zapata et al.
GENOME BIOLOGY (2018)
ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma
M. Hazawa et al.
ONCOGENE (2017)
The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma
Sharmilan Thanendrarajan et al.
HAEMATOLOGICA (2017)
New development in CAR-T cell therapy
Zhenguang Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Clinical significance of ZNF750 gene expression, a novel tumor suppressor gene, in esophageal squamous cell carcinoma
Sho Nambara et al.
ONCOLOGY LETTERS (2017)
The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma
Sharmilan Thanendrarajan et al.
HAEMATOLOGICA (2017)
BRCA mutation in ovarian cancer: testing, implications and treatment considerations
Robert T. Neff et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan et al.
CELL (2017)
Universal Patterns of Selection in Cancer and Somatic Tissues
Inigo Martincorena et al.
CELL (2017)
CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting
D. G. Courtney et al.
GENE THERAPY (2016)
Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries
Ava Kwong et al.
JOURNAL OF MEDICAL GENETICS (2016)
Loss of Heterozygosity of 9p Is Associated with Poorer Survival in Patients with Gliomas
Tingfen Huang et al.
MOLECULAR NEUROBIOLOGY (2016)
Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer
Guanglong Jiang et al.
BMC GENOMICS (2016)
Targeting MYC: is it getting any easier?
Giovanna Zinzalla
FUTURE MEDICINAL CHEMISTRY (2016)
RB1: a prototype tumor suppressor and an enigma
Nicholas J. Dyson
GENES & DEVELOPMENT (2016)
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
Liacine Bouaoun et al.
HUMAN MUTATION (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
The regulation and functions of the nuclear RNA exosome complex
Cornelia Kilchert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Conflicting HLA assignment by three different typing methods due to the apparent loss of heterozygosity in the MHC region
T. Linjama et al.
HLA (2016)
PureCN: copy number calling and SNV classification using targeted short read sequencing
Markus Riester et al.
SOURCE CODE FOR BIOLOGY AND MEDICINE (2016)
Partial PTEN deletion is linked to poor prognosis in breast cancer
P. Lebok et al.
BMC CANCER (2015)
Loss of heterozygosity: what is it good for?
Georgina L. Ryland et al.
BMC MEDICAL GENOMICS (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R. Carter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K. Brastianos et al.
CANCER DISCOVERY (2015)
ARID1B-mediated disorders: Mutations and possible mechanisms
Joe C. H. Sim et al.
INTRACTABLE & RARE DISEASES RESEARCH (2015)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
Laxmi Silwal-Pandit et al.
CLINICAL CANCER RESEARCH (2014)
Complex correlations: replication timing and mutational landscapes during cancer and genome evolution
Jiao Sima et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
Jacques W. M. Lenders et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Putative cis-regulatory drivers in colorectal cancer
Halit Ongen et al.
NATURE (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
canSAR: updated cancer research and drug discovery knowledgebase
Krishna C. Bulusu et al.
NUCLEIC ACIDS RESEARCH (2014)
Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
Mariam Jamal-Hanjani et al.
PLOS BIOLOGY (2014)
OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes
David Tamborero et al.
BIOINFORMATICS (2013)
MYELOID NEOPLASIA CUX1 in leukemia: dosage matters
Jacqueline Boultwood
BLOOD (2013)
Oct transcription factors in development and stem cells: insights and mechanisms
Dean Tantin
DEVELOPMENT (2013)
Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma
Alissa Michelle Go Wong et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
Ivana Jochmanova et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
A c-Myc Activation Sensor-Based High-Throughput Drug Screening Identifies an Antineoplastic Effect of Nitazoxanide
Hua Fan-Minogue et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
Loss of heterozygosity preferentially occurs in early replicating regions in cancer genomes
Brent S. Pedersen et al.
NUCLEIC ACIDS RESEARCH (2013)
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhengping Zhuang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
canSAR: an integrated cancer public translational research and drug discovery resource
Mark D. Halling-Brown et al.
NUCLEIC ACIDS RESEARCH (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
New plays in the p53 theater
Yael Aylon et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
Christine O'Keefe et al.
BLOOD (2010)
Aberrant Fatty Acid-Binding Protein-7 Gene Expression in Cutaneous Malignant Melanoma
Yasufumi Goto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Association Between TP53 Gene ARG72PRO Polymorphism and Chromosome Aberrations in Human Cancers
Nicolay V. Litviakov et al.
MOLECULAR CARCINOGENESIS (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Loss of heterozygosity of TRIM3 in malignant gliomas
Jean-Louis Boulay et al.
BMC CANCER (2009)
A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress
Jinsuk Kang et al.
GENES & DEVELOPMENT (2009)
Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity
Arvind Shakya et al.
NATURE CELL BIOLOGY (2009)
Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma
Yan Ru Qin et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Risk estimation of neuroblastoma patients using molecular markers
M. Fischer et al.
KLINISCHE PADIATRIE (2008)
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
M. Campoli et al.
ONCOGENE (2008)
Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns
I. A. Lea et al.
CARCINOGENESIS (2007)
p53 in health and disease
Karen H. Vousden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome
Matthias Fischer et al.
CLINICAL CANCER RESEARCH (2006)
LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer
Marianne Kyndi et al.
ACTA ONCOLOGICA (2006)
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number
Qun Wang et al.
CANCER RESEARCH (2006)
Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer
YJ Hu et al.
JOURNAL OF NUTRITION (2005)
Chromosome 1p and 11q deletions and outcome in neuroblastoma
EF Attiyeh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias
J Fitzgibbon et al.
CANCER RESEARCH (2005)
Brain lipid-binding protein is a direct target of Notch signaling in radial glial cells
TE Anthony et al.
GENES & DEVELOPMENT (2005)
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
Y Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis
S Popat et al.
EUROPEAN JOURNAL OF CANCER (2005)
Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q
L Sarli et al.
DISEASES OF THE COLON & RECTUM (2004)
Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers
YC Lee et al.
BRITISH JOURNAL OF CANCER (2004)
Allelic variation in gene expression is common in the human genome
HS Lo et al.
GENOME RESEARCH (2003)
Fluorescence in situ hybridization analyses of chromosome band I p36 in neuroblastoma detect two classes of alterations
R Spitz et al.
GENES CHROMOSOMES & CANCER (2002)
Direct correlation between FRA3B expression and cigarette smoking
CK Stein et al.
GENES CHROMOSOMES & CANCER (2002)
分享论文
